PHIO Earnings Phio Pharmaceuticals Corp.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–18 of 18
| Q2 2025 | 2025-06-30 | -0.86 | 2025-08-14 | 10-Q |
| Q1 2025 | 2025-03-31 | -0.41 | 2025-05-15 | 10-Q |
| FY 2024 | 2024-12-31 | -9.08 | 2025-03-31 | 10-K |
| Q3 2024 | 2024-09-30 | -8.23 | 2024-11-14 | 10-Q |
| Q2 2025 | 2024-06-30 | -7.85 | 2025-08-14 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.47 | 2025-05-15 | 10-Q |
| FY 2024 | 2023-12-31 | -46.76 | 2025-03-31 | 10-K |
| Q3 2024 | 2023-09-30 | -45.28 | 2024-11-14 | 10-Q |
| Q2 2024 | 2023-06-30 | -38.52 | 2024-08-14 | 10-Q |
| Q1 2024 | 2023-03-31 | -3.15 | 2024-05-09 | 10-Q |
| FY 2023 | 2022-12-31 | -10.10 | 2024-04-01 | 10-K |
| Q3 2023 | 2022-09-30 | -7.70 | 2023-11-09 | 10-Q |
| Q2 2023 | 2022-06-30 | -4.56 | 2023-08-10 | 10-Q |
| Q1 2023 | 2022-03-31 | -2.34 | 2023-05-11 | 10-Q |
| FY 2022 | 2021-12-31 | -12.43 | 2023-03-22 | 10-K |
| Q3 2022 | 2021-09-30 | -0.78 | 2022-11-10 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.50 | 2022-08-11 | 10-Q |
| Q1 2022 | 2021-03-31 | -0.32 | 2022-05-12 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.